HanchorBio | ApexOnco - Clinical Trials news and analysis

x

“OncologyPipeline is my favorite CI tool”

Monika Vogelmann

Head of Market Insights Oncology Europe

Daiichi Sankyo

Click here for more information

Data insights

9 July 2024

ALX has a Chinese challenger

HanchorBio’s HCB301 is among the latest industry projects beginning first-in-human trials.

Subscribe to HanchorBio